# Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer

> **NCT01980823** · EARLY_PHASE1 · COMPLETED · sponsor: **Columbia University** · enrollment: 23 (actual)

## Conditions studied

- Breast Cancer
- Breast Tumors
- Cancer of Breast

## Interventions

- **DRUG:** Metformin
- **DRUG:** Atorvastatin
- **PROCEDURE:** Breast surgery

## Key facts

- **NCT ID:** NCT01980823
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2018-05-24
- **Final completion:** 2022-12
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01980823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01980823, "Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01980823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*